Q2 2026 saw a 2% revenue increase and significant profit recovery, with net income up 180% and adjusted EBITDA up 13% year-over-year. Margin recovery initiatives and cost controls drove improved results, while guidance anticipates continued WSEE declines but higher adjusted EPS and EBITDA for the f…
Q2 2026 saw a 2% revenue increase and significant profit recovery, with net income up 180% and adjusted EBITDA up 13% year-over-year. Margin recovery initiatives and cost controls drove improved results, while guidance anticipates continued WSEE declines but higher adjusted EPS and EBITDA for the full year.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.
